Drug Shortage Report for SAXENDA
Report ID | 213933 |
Drug Identification Number | 02437899 |
Brand name | SAXENDA |
Common or Proper name | SAXENDA® 6 MG/ML 5X3 ML |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LIRAGLUTIDE |
Strength(s) | 6MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | EA |
ATC code | A10BJ |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-12-20 |
Actual start date | 2023-12-20 |
Estimated end date | 2024-01-05 |
Actual end date | 2024-01-02 |
Shortage status | Resolved |
Updated date | 2024-01-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-12-20 | English | Compare |
v2 | 2023-12-20 | English | Compare |
v3 | 2023-12-20 | English | Compare |
v4 | 2023-12-20 | French | Compare |
v5 | 2023-12-21 | English | Compare |
v6 | 2024-01-02 | English | Compare |
v7 | 2024-01-02 | French | Compare |
v8 | 2024-01-03 | English | Compare |
Showing 1 to 8 of 8